The latest added platforms

Spark Crowdfunding is a Dublin-based equity crowdfunding platform that allows investors to fund Irish companies at low costs and quick pace.

Aescuvest: a FinTech platform dedicated to financing healthcare solutions. Investors can build personalized portfolios and participate in healthcare investment opportunities via SPV structures. Aescuvest has raised over 30 million Euro.

Exporo offers an innovative platform for small investors to invest in real estate projects starting at €100. It allows investors to participate in high-yield real estate projects and also directly invest in selected existing properties, receiving quarterly distributions and participating in value growth.

Companisto is an investment platform for startups with a focus on lean processes and efficient solutions. They support the start-up culture in Germany and Europe by partnering with business angels and investors.

Ulule is a community-driven incubator for positive impact projects. Empowers people to create and grow ideas for a sustainable and diverse world.

Koregraf is a French platform exclusively dedicated to crowdfunding real estate. Minimum investment amount is €2,000 with investment duration from 12 to 24 months. Expected profitability is from 8% to 10% per annum.

WiSEED is a French crowdfunding platform established in 2008, enabling individuals to invest in diversified portfolios and providing businesses with fast financing solutions.

Fundimmo is a real estate crowdfunding platform that offers investment opportunities in diverse projects from €1,000 and above, selected by a team of real estate professionals.

Immovesting democratizes real estate investments by providing diverse, global opportunities to individuals. The platform offers various strategies, property types, and investment arrangements.

Immocratie is a real estate crowdfunding platform that offers short-term investment opportunities with rates of return between 10 and 12% per year. Private investors can contribute funds to experienced promoters.